Why CTI BioPharma Stock Blasted 18% Higher Today
The stock of CTI BioPharma (NASDAQ: CTIC) was an outlier in the biotech sector on Thursday, and in the best way possible. The company's shares surged more than 18% higher on the day, following a new and bullish analyst note on the company based on positive anecdotal evidence. Peaker rates it an unequivocal outperform (read: buy), at a price target of $10 per share.